“Could the use of nanomedicines be a breakthrough for breast cancer treatment?”
| dc.contributor.advisor | Dr Christine Dufès | |
| dc.contributor.author | Bayan Ahmed Abdulrazzaq Alkhaldi | |
| dc.date | 2020 | |
| dc.date.accessioned | 2022-05-29T14:43:10Z | |
| dc.date.available | 2022-05-29T14:43:10Z | |
| dc.degree.department | Advanced Drug Delivery | |
| dc.degree.grantor | Strathclyde Institute of Pharmacy and Biomedical Sciences, University of Strathclyde | |
| dc.description.abstract | Critical analysis discussing the use of nanomedicines in the treatment of breast cancer: The advantages and disadvantages of currently available nanomedicines in comparison with conventional treatments in breast cancer. It also mention the future of nanomedicines in breast cancer treatment. | |
| dc.identifier.uri | https://drepo.sdl.edu.sa/handle/20.500.14154/49018 | |
| dc.language.iso | en | |
| dc.title | “Could the use of nanomedicines be a breakthrough for breast cancer treatment?” | |
| sdl.thesis.level | Master | |
| sdl.thesis.source | SACM - United Kingdom |